Student Name
Capella University
NURS-FPX 4030 Making Evidence-Based Decisions
Prof. Name
Date
PICO (T) Questions and Evidence-Based Approach
PICO(T) is a widely recognized framework in Evidence-Based Practice (EBP) that assists healthcare professionals in structuring clinical inquiries effectively. The acronym stands for Population, Intervention, Comparison, Outcome, and Time, allowing a systematic approach to evaluating research questions and identifying high-quality evidence (Kloda et al., 2020). Stroke is a complex acute neurological disorder caused by vascular injury, resulting in either cerebral hemorrhage or infarction, rather than a single medical condition. It is influenced by various risk factors, comorbidities, and pathophysiological mechanisms (Murphy & Werring, 2020). This assessment focuses on a PICO(T) question addressing stroke prevention through antihypertensive therapy.
Exploration of Practice Issue
The epidemiology of stroke in the United States has evolved, yet the condition remains a major public health concern. Stroke ranks as the fifth leading cause of death in the country, contributing to over 140,000 fatalities annually. Financially, the healthcare burden is significant, with costs exceeding $34 billion per year (Khan et al., 2021). Stroke is also the leading cause of long-term physical disability among adults. Among modifiable risk factors, hypertension is the most significant, with its impact varying according to stroke subtype (Murphy & Werring, 2020). Understanding these dynamics is critical for designing effective secondary prevention strategies.
PICO(T) Question
Ischaemic stroke individuals (P) use antihypertensive medications (I), compared to patients not taking antihypertensive medicines (C), reduce the rate of recurrent stroke (O), over a 12-month period (T)?
| Component | Description |
|---|---|
| Population (P) | Adults who have experienced an ischemic stroke. |
| Intervention (I) | Administration of antihypertensive medications to manage blood pressure. |
| Comparison (C) | Stroke patients not receiving antihypertensive therapy. |
| Outcome (O) | Reduction in the rate of recurrent ischemic stroke. |
| Time (T) | 12 months following the initial stroke event. |
Benefits of the PICO(T) Approach
The PICO(T) model is highly valued in nursing and clinical research for its ability to clarify and structure complex clinical questions. By breaking down inquiries into discrete components, it enhances the efficiency and accuracy of literature searches, facilitates evidence synthesis, and supports the development of standardized care protocols (Schiavenato & Chu, 2021). Specifically, in stroke care, PICO(T) enables clinicians to evaluate hypertension management interventions systematically. Evidence shows that patients treated with antihypertensive medications during or after stroke demonstrate a decreased risk of recurrence, highlighting the practical importance of structured clinical questions in improving patient outcomes (Jørgensen et al., 2022; Kloda et al., 2020).
Sources of Evidence
Reliable evidence for evaluating this PICO(T) question comes from peer-reviewed journals, clinical trials, and authoritative institutional guidelines (Kattie, 2021). Elevated blood pressure is the most frequent clinical finding in acute ischemic stroke (AIS). Randomized controlled trials comparing antihypertensive therapy with non-treatment provide critical data regarding efficacy, safety, and long-term outcomes (Whelton et al., 2018). Dawson et al. (2022) emphasize that antihypertensive medications are essential for secondary stroke prevention. Additionally, meta-analyses and systematic reviews synthesize data from diverse sources, offering insights into treatment effects on neurological recovery and functional outcomes (García-Rudolph et al., 2019).
Clinical guidelines from organizations such as the American Heart Association (AHA) compile evidence-based recommendations to inform clinical decision-making for patients with acute ischemic stroke (Powers et al., 2019). These guidelines provide actionable strategies for clinicians, hospital administrators, and allied health professionals to optimize care quality and reduce stroke recurrence.
Rationale
Blood pressure plays a pivotal role in the pathophysiology and outcomes of ischemic stroke. Maintaining blood pressure below 150/90 mmHg is associated with a lower incidence of recurrent stroke, while hypertensive emergencies directly exacerbate cerebral injury (Wajngarten & Silva, 2019). The PICO(T) approach allows for the assessment of both immediate and long-term effects of antihypertensive therapy on stroke-related morbidity and mortality. Coordinated management of blood pressure is crucial to minimizing secondary brain injury and improving functional recovery.
Findings from Sources of Evidence
Hypertension is consistently identified as a leading modifiable risk factor for stroke. Elevated systolic-to-diastolic ratios correlate with a higher likelihood of stroke occurrence (Wajngarten & Silva, 2019). Evidence supports that antihypertensive therapy substantially reduces the risk of stroke recurrence. Clinical recommendations are often formulated using the GRADE framework (Grading of Recommendations, Assessment, Development, and Evaluation), ensuring treatment protocols are evidence-based and standardized.
Primordial prevention strategies—such as sodium restriction, balanced nutrition, tobacco cessation, and promoting supportive environments—also contribute to stroke risk reduction (Wajngarten & Silva, 2019). Lifestyle factors, including physical inactivity and poor dietary habits, are directly linked to hypertension and stroke risk (Kuriakose & Xiao, 2020). These findings underscore the need for a multidisciplinary approach combining pharmacologic and behavioral interventions.
Credibility of Resources
The referenced evidence meets the CRAAP criteria (Currency, Relevance, Authority, Accuracy, Purpose). Studies indicate that 9% to 15% of stroke patients experience recurrence within one year, highlighting the necessity of preventive interventions. Dawson et al. (2022) advocate antihypertensive therapy to mitigate this risk, and these findings inform clinical protocols for hypertension management in stroke survivors (Bulto et al., 2023). Trusted databases, such as PubMed, Google Scholar, and the American Stroke Foundation, provide reliable, peer-reviewed resources.
Relevance of these Findings
Current stroke management emphasizes careful monitoring of cardiovascular parameters. Effective blood pressure control remains a clinical challenge, particularly before thrombolytic therapy, where systolic pressure must be reduced below 185 mmHg and diastolic pressure below 110 mmHg (Bath et al., 2022). Understanding these parameters is essential to ensuring patient safety and optimizing outcomes.
Relevant Findings Lead to Positive Outcomes
Evidence from the Florida Stroke Registry indicates that appropriate antihypertensive therapy during acute stroke significantly improves patient outcomes (Gillian Gordon Perue et al., 2023). Clinical recommendations advocate maintaining blood pressure below 130/80 mmHg, with stricter targets (<140/90 mmHg) for high-risk ischemic stroke patients and <120/80 mmHg for those at elevated risk of hemorrhagic stroke. The selection of antihypertensive therapy should consider individual patient risk profiles and stroke subtype, ensuring a personalized and evidence-based approach (Hemphill et al., 2015).
References
Bath, P. M., Song, L., Silva, G. S., Mistry, E., Petersen, N., Tsivgoulis, G., Mazighi, M., Bang, O. Y., & Sandset, E. C. (2022). Blood Pressure Management for Ischemic Stroke in the First 24 Hours. Stroke, 53(4), 1074–1084. https://doi.org/10.1161/strokeaha.121.036143
Bulto, L. N., Roseleur, J., Noonan, S., Pinero de Plaza, M. A., Champion, S., Dafny, H. A., Pearson, V., Nesbitt, K., Gebremichael, L. G., Beleigoli, A., Schultz, T., Hines, S., Clark, R. A., & Hendriks, J. M. (2023). Effectiveness of nurse-led interventions versus usual care to manage hypertension and lifestyle behavior: A systematic review and meta-analysis. European Journal of Cardiovascular Nursing. https://doi.org/10.1093/eurjcn/zvad040
Dawson, J., Béjot, Y., Christensen, L. M., De Marchis, G. M., Dichgans, M., Hagberg, G., Heldner, M. R., Milionis, H., Li, L., Pezzella, F. R., Taylor Rowan, M., Tiu, C., & Webb, A. (2022). European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. European Stroke Journal, 239698732211000. https://doi.org/10.1177/23969873221100032
García-Rudolph, A., Sánchez-Pinsach, D., Salleras, E. O., & Tormos, J. M. (2019). Subacute stroke physical rehabilitation evidence in activities of daily living outcomes. Medicine, 98(8), e14501. https://doi.org/10.1097/md.0000000000014501
Gillian Gordon Perue, Ying, H., Bustillo, A. J., Zhou, L., Gutierrez, C. M., Wang, K., Gardener, H., Krigman, J., Jameson, A., Foster, D., Dong, C., Tatjana Rundek, Rose, D. Z., Romano, J. G., Ayham Alkhachroum, Sacco, R., Asdaghi, N., & Koch, S. (2023). A 10-year review of antihypertensive prescribing practices after stroke and the associated disparities from the Florida Stroke Registry. https://doi.org/10.1101/2023.02.15.23286003
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., Scott, P. A., Selim, M. H., & Woo, D. (2015). Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke, 46(7), 2032–2060. https://doi.org/10.1161/str.0000000000000069
NURS FPX 4030 Assessment 3 Picot Questions and an Evidence Based Approach
Jørgensen, J. M. A., Christensen, D. L., Nielsen, K. K., Sadiq, H. S., Khan, M. Y., Jusabani, A. M., & Walker, R. (2022). Incidence and characteristics of stroke in Zanzibar – a hospital-based prospective study in a low-income island population. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.931915
Khan, S. U., Khan, M. Z., Khan, M. U., Khan, M. S., Mamas, M. A., Rashid, M., Blankstein, R., Virani, S. S., Johansen, M. C., Shapiro, M. D., Blaha, M. J., Cainzos-Achirica, M., Vahidy, F. S., & Nasir, K. (2021). Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002–2017. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 5(2), 431–441. https://doi.org/10.1016/j.mayocpiqo.2021.01.015
Kloda, L. A., Boruff, J. T., & Soares Cavalcante, A. (2020). A comparison of patient, intervention, comparison, outcome (PICO) to a new, alternative clinical question framework for search skills, search results, and self-efficacy: a randomized controlled trial. Journal of the Medical Library Association, 108(2). https://doi.org/10.5195/jmla.2020.739
Kuriakose, D., & Xiao, Z. (2020). Pathophysiology and treatment of stroke: Present status and future perspectives. International Journal of Molecular Sciences, 21(20), 7609. https://doi.org/10.3390/ijms21207609
Murphy, S. JX., & Werring, D. J. (2020). Stroke: Causes and Clinical Features. Medicine, 48(9), 561–566. https://doi.org/10.1016/j.mpmed.2020.06.002
NURS FPX 4030 Assessment 3 Picot Questions and an Evidence Based Approach
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., & Tirschwell, D. L. (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update. Stroke, 50(12). https://doi.org/10.1161/str.0000000000000211
Schiavenato, M., & Chu, F. (2021). PICO: What it is and what it is not. Nurse Education in Practice, 56(1). https://doi.org/10.1016/j.nepr.2021.103194
Wajngarten, M., & Silva, G. S. (2019). Hypertension and Stroke: Update on Treatment. European Cardiology Review, 14(2), 111–115. https://doi.org/10.15420/ecr.2019.11.1
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., & Williamson, J. D. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 71(6). https://doi.org/10.1161/hyp.0000000000000065